American Healthcare REIT (NYSE:AHR) Announces Quarterly Earnings Results

American Healthcare REIT (NYSE:AHR) posted its earnings results on Tuesday. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.35), Zacks reports. The firm had revenue of $523.81 million for the quarter, compared to analysts’ expectations of $474.26 million. American Healthcare REIT had a negative return on equity of 1.96% and a negative net margin of 1.84%. The company’s revenue for the quarter was up 12.8% on a year-over-year basis. American Healthcare REIT updated its FY24 guidance to $1.40-1.43 EPS and its FY 2024 guidance to 1.400-1.430 EPS.

American Healthcare REIT Stock Performance

AHR stock opened at $26.25 on Friday. American Healthcare REIT has a 1 year low of $12.63 and a 1 year high of $27.77. The company has a market cap of $3.46 billion and a P/E ratio of -54.69. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.29 and a quick ratio of 0.29. The stock’s fifty day moving average price is $25.16 and its 200-day moving average price is $19.21.

American Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 18th. Shareholders of record on Friday, September 20th were paid a dividend of $0.25 per share. The ex-dividend date was Friday, September 20th. This represents a $1.00 dividend on an annualized basis and a yield of 3.81%. American Healthcare REIT’s dividend payout ratio is presently -208.33%.

Analyst Upgrades and Downgrades

AHR has been the topic of several recent research reports. Morgan Stanley upped their price target on American Healthcare REIT from $17.00 to $22.00 and gave the stock an “overweight” rating in a research note on Thursday, August 22nd. Truist Financial increased their price target on shares of American Healthcare REIT from $22.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. KeyCorp lifted their target price on shares of American Healthcare REIT from $16.00 to $27.00 and gave the company an “overweight” rating in a report on Monday, September 16th. Colliers Securities upgraded American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research note on Sunday, October 13th. Finally, JMP Securities boosted their target price on American Healthcare REIT from $18.00 to $30.00 and gave the stock a “market outperform” rating in a report on Friday, September 20th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $23.00.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.